Interestingly, we found both IDH1/2 genes mostly prevalent in two subtypes of gliomas: astrocytoma and oligodendrogliomas with a frequency of 71.4 and 85.7% for IDH1 and 14.28 and 28.5% for IDH2, respectively. This evidence concerns the gene IDH1 and central nervous system cancer.